“…The clinical significance of glucose metabolism and its role in atherosclerotic CVD and Type 2 diabetes has been well documented (Bavenholm et al, 1995; Bjornholt et al, 1999; Bonora et al, 2002; Broomhead & Colvin, 2001; Coutinho, Gerstein, Wang, & Yusuf, 1999; Dandona, Aljada, Chaudhuri, & Bandyopadhyay, 2003; Ferrannini, Haffner, Mitchell, & Stern, 1991; Gerstein, Pais, Pogue, & Yusuf, 1999; Howard et al, 1996; Onat et al, 2002; G. M. Reaven, 1988; Sasso et al, 2004).…”